As of 2025-09-18, the Relative Valuation of Avidity Biosciences Inc (RNA) is (70.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 41.44 USD, the upside of Avidity Biosciences Inc based on Relative Valuation is -269.0%.
The range of the Relative Valuation is (59.51) - (72.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (59.51) - (72.62) | (70.05) |
| Upside | -243.6% - -275.2% | -269.0% |
| Date | P/E |
| 2025-09-16 | -11.70 |
| 2025-09-15 | -11.35 |
| 2025-09-12 | -12.63 |
| 2025-09-11 | -11.59 |
| 2025-09-10 | -13.10 |
| 2025-09-09 | -13.16 |
| 2025-09-08 | -13.56 |
| 2025-09-05 | -14.22 |
| 2025-09-04 | -13.68 |
| 2025-09-03 | -13.43 |
| 2025-09-02 | -13.33 |
| 2025-08-29 | -13.15 |
| 2025-08-28 | -13.71 |
| 2025-08-27 | -13.50 |
| 2025-08-26 | -13.28 |
| 2025-08-25 | -12.78 |
| 2025-08-22 | -13.08 |
| 2025-08-21 | -12.61 |
| 2025-08-20 | -12.52 |
| 2025-08-19 | -12.43 |
| 2025-08-18 | -12.56 |
| 2025-08-15 | -13.12 |
| 2025-08-14 | -13.00 |
| 2025-08-13 | -13.03 |
| 2025-08-12 | -13.05 |
| 2025-08-11 | -12.92 |
| 2025-08-08 | -13.07 |
| 2025-08-07 | -13.41 |
| 2025-08-06 | -13.62 |
| 2025-08-05 | -10.80 |
| 2025-08-04 | -10.54 |
| 2025-08-01 | -10.14 |
| 2025-07-31 | -10.36 |
| 2025-07-30 | -10.41 |
| 2025-07-29 | -10.15 |
| 2025-07-28 | -9.76 |
| 2025-07-25 | -10.24 |
| 2025-07-24 | -9.37 |
| 2025-07-23 | -9.58 |
| 2025-07-22 | -9.47 |
| 2025-07-21 | -9.60 |
| 2025-07-18 | -9.53 |
| 2025-07-17 | -9.61 |
| 2025-07-16 | -9.47 |
| 2025-07-15 | -8.95 |
| 2025-07-14 | -9.48 |
| 2025-07-11 | -8.88 |
| 2025-07-10 | -8.88 |
| 2025-07-09 | -8.83 |
| 2025-07-08 | -8.26 |